基因工程药物的质量控制

随着基因工程药物产品的日益增多,对其进行严格的质量控制已愈显重要。本文分别就产品的鉴定以及纯度、活性、安全性、稳定性和一致性的评价这六个方面对该质控系统进行了阐述,同时还分析了目前所用的多种检测方法的特点。基因工程药物产品中残余杂质的限量分析也是本文着重探讨的内容之一。     

杂质对蛋白质晶体影响研究进展

综述了杂质对蛋白质晶体生长影响研究领域的进展情况. 对可能的杂质来源以及杂质对结晶过程的影响进行了介绍.重点介绍了和结晶蛋白质分子结构相似的杂质分子的影响, 包括晶体成核、生长形态、表面形貌、生长动力学、质量等,以及杂质在晶体中的重新分配.     

山羊毛提取L-胱氨酸杂质源及其除杂工艺

山羊毛提取L 胱氨酸过程中伴有上百种有机类、无机类杂质的形成 ,分析杂质的形成过程及其对胱氨酸收率和产品质量的影响 ,采用料毛物理化学法除杂、活性炭两次脱色、三次中和重结晶除杂工艺 ,杂质除净率高 ,L 胱氨酸产品质量达HG 2 0 30 - 91优质品标准。     

红色诺卡氏菌Nr-8206株培养形态与其有效物质及杂质关系分析

筛选红色诺卡氏菌（Nocardia rubra）Nr-8206株适宜投产的最佳培养形态。将红色诺卡氏菌Nr-8206株复壮,通过涂布、形态学考察筛选典型菌落形态。通过发酵技术获得各种菌落形态菌株的生物量,进一步通过细胞破碎、化学提纯等方法获得细胞壁多糖产物,紫外可见光分光光度法进行有效物质含量测定及杂质的检测。结果表明,红色诺卡氏菌Nr-8206株的最佳菌落形态为菌落直径1.68 mm、橘色、有突起、有褶皱、菌落边缘丝状,编号RY2。进行菌株RY2发酵,其菌体量最多,经破碎、提纯后,其有效物质糖含量及胞壁酸含量均高于其他形态的菌落,并高于出发菌株Nr-8206,且其杂质蛋白质残余量更低,杂质更容易去除。该研究可供生产企业以该菌株作为工作菌株时提供形态选择参考。     

重组腺相关病毒载体相关性杂质

可以稳定表达治疗基因而无明显不良反应的重组腺相关病毒 (rAAV) 载体被认为是最有发展前景的基因治疗载体。但如何建立可以有效去除rAAV载体内具有潜在致病危害的杂质、产品质量符合临床使用要求的纯化工艺是研究人员面临的巨大挑战。其中针对载体相关性杂质的纯化工艺尤为关键,因为该类杂质的性质与真正的rAAV载体极其相似,一旦存在便难以去除,且会引起严重不良反应。以下总结了该类杂质形成的过程及有别于rAAV载体的特点,并对可以防止其生成或将其与rAAV载体有效分离的技术手段进行了评价。     

重组腺相关病毒载体相关性杂质

可以稳定表达治疗基因而无明显不良反应的重组腺相关病毒(rAAV)载体被认为是最有发展前景的基因治疗载体。但如何建立可以有效去除rAAV载体内具有潜在致病危害的杂质、产品质量符合临床使用要求的纯化工艺是研究人员面临的巨大挑战。其中针对载体相关性杂质的纯化工艺尤为关键,因为该类杂质的性质与真正的rAAV载体极其相似,一旦存在便难以去除,且会引起严重不良反应。以下总结了该类杂质形成的过程及有别于rAAV载体的特点,并对可以防止其生成或将其与rAAV载体有效分离的技术手段进行了评价。     

高效液相检测醋酸氢化可的松杂质的方法建立

目的:建立高效液相法测定醋酸氢化可的松中杂质的检测方法。方法:采用色谱柱:Agela Venusil MP C18 4.6×250mm,流动相:磷酸盐缓冲液(取8mmol/L磷酸二氢钾溶液,用8mmol/L磷酸氢二钾溶液调节PH值至5.0,临用新制)-甲醇(62:38);检测波长:254nm;柱温:40℃测定。结果:采用此高效液相法能将杂质与主成分有效分离,专属性良好,准去度高,8小时内溶液较稳定,耐用性强,经检测限试验证明该方法能有效检出杂质。结论:该方法简便,准确度高,专属性好,建议采用高效液相法测定醋酸氢化可的松的杂质。     

蛋白A亲和层析法纯化单克隆抗体工艺的优化

治疗性单克隆抗体药物已成为生物医药领域市场最主要的产品类别。蛋白A亲和层析作为第一步捕获抗体蛋白最为有效的手段仍然在现有单克隆抗体纯化平台中占据主导地位。在本研究中,首先开发了一种基于低p H处理抗体细胞回收液的新型细胞液回收技术,该技术能有效去除宿主相关污染物(非组蛋白宿主杂质蛋白、组蛋白、DNA、蛋白聚合物等),同时保证较高的抗体回收率。通过该技术有效预处理后,蛋白A纯化效率可提高10倍左右,并且有效避免了抗体洗脱液中和后浊度的上升,大大减轻了后续蛋白纯化的压力。同时我们也对酸性处理中各种宿主杂质去除机制进行了研究。然后,预处理的洗脱液再经一步Capto adhere色谱纯化,非组蛋白宿主杂质蛋白降低至5 ppm、DNA小于1 ppb、组蛋白降低至检测限以下、蛋白聚合物小于0.01%。总过程抗体蛋白收率87%。该两步法抗体纯化技术可有效集成至当前主流抗体纯化平台,具有良好的大规模应用价值。     

基于液质联用技术解析和降低螺旋霉素发酵杂质

目前螺旋霉素生物合成的发酵杂质含量过高 ,导致成品收率过低 ,杂质含量不符合药典规定。为解决这一问题 ,首先利用LC -MS联用技术定性分析了 4种螺旋霉素发酵杂质的结构 ,结合螺旋霉素生物合成途径分析 ,它们都起因于螺旋霉素生物合成糖基化过程的紊乱。氮源尤其是铵盐对螺旋霉素生物合成糖基化过程有重要的调节作用。进一步的氮源优化使螺旋霉素发酵液中 4种杂质含量降低 22%～88% ,杂质含量全部低于欧洲药典标准。     

药物分析技术应用研究新进展

通过对2012 年我国学者在国内外发表的有关药物分析技术应用研究论文进行检索和整理,分类综述针对化学药物、基因工程药物以及中药等各类药物或生物样本的过程分析技术、高通量筛选分析技术、固态性质表征分析技术、杂质谱检测分析技术、体内样本分析技术、中药分析技术、生化药物分析技术等的应用研究新进展。     

仿制药一致性评价中有关物质研究的思考

有关物质是药品的关键质量属性之一,也是仿制药一致性评价的重要内容,其涉及药品的安全性及其质量的可控性。文章梳理了 仿制药有关物质的来源及研究重点,评估仿制药有关物质的文献分析方法,总结归纳仿制药与被仿制药实际样品的杂质谱分析比较及其 意义,探讨杂质限度的确定原则与方法。     

Effects of solution environment on mammalian cell fermentation broth properties: Enhanced impurity removal and clarification performance

The processing of recombinant proteins from high cell density, high product titer cell cultures containing mammalian cells is commonly performed using tangential flow microfiltration (MF). However, the increased cellular debris present in these complex feed streams can prematurely foul the membrane, adversely impacting MF capacity and throughput. In addition, high cell density cell culture streams introduce elevated levels of process‐related impurities, which increase the burden on subsequent purification operations to remove these complex media components and impurities. To address this challenge, an evaluation of mammalian cell culture broth buffer properties was examined to determine if enhanced impurity removal and clarification performance could be achieved. A framework is presented here for establishing optimized mammalian cell culture buffer conditions, involving trade‐offs between product recovery and purification and improved clarification at manufacturing‐scale production. A reduction in cell culture broth pH to 4.7–5.0 induced flocculation and impurity precipitation which increased the average feed particle‐size. These conditions led to enhanced impurity removal and improved MF throughput and filter capacity for several mammalian systems. Feed conditions were further optimized by controlling ionic composition along with pH to improve product recovery from high cell density/high product titer cell cultures. Biotechnol. Bioeng. 2011; 108:50–58. © 2010 Wiley Periodicals, Inc.     

An Artifact in the ESR Spectrum Obtained by Spin Trapping with Dmpo

In order to overcome a common problem in spin trapping with high concentrations of 5.5-dimethyl-I-pyrroline-N-oxide (DMPO) where ESR spectra are obtained which include an unidentified set of lines composed of a triplet of doublets. commercial DMPO was analyzed for its impurities by high-performance liquid chromatography. mass spectrometry. and nuclear magnetic resonance spectroscopy. It has been determined that this undesirable ESR spectrum IS due to an impurity included in the spin trap. This compound has been assigned to the hydronylunine which is a DMPO-derivative having an epoxy ring located at the 2 and 3 positions.     

Impact of iron raw materials and their impurities on CHO metabolism and recombinant protein product quality

Cell culture medium (CCM) composition affects cell growth and critical quality attributes (CQAs) of monoclonal antibodies (mAbs) and recombinant proteins. One essential compound needed within the medium is iron because of its central role in many cellular processes. However, iron is also participating in Fenton chemistry leading to the formation of reactive oxygen species (ROS) causing cellular damage. Therefore, this study sought to investigate the impact of iron in CCM on Chinese hamster ovary (CHO) cell line performance, and CQAs of different recombinant proteins. Addition of either ferric ammonium citrate (FAC) or ferric citrate (FC) into CCM revealed major differences within cell line performance and glycosylation pattern, whereby ammonium was not involved in the observed differences. Inductively coupled plasma mass spectrometry (ICP-MS) analysis identified varying levels of impurities present within these iron sources, and manganese impurity rather than iron was proven to be the root cause for increased cell growth, titer, and prolonged viability, as well as altered glycosylation levels. Contrary effects on cell performance and protein glycosylation were observed for manganese and iron. The use of low impurity iron raw material is therefore crucial to control the effect of iron and manganese independently and to support and guarantee consistent and reproducible cell culture processes.     

Salt tolerant membrane adsorbers for robust impurity clearance

Clearance of impurities such as viruses, host cell protein (HCP), and DNA is a critical purification design consideration for manufacture of monoclonal antibody therapeutics. Anion exchange chromatography has frequently been utilized to accomplish this goal; however, anion exchange adsorbents based on the traditional quaternary amine (Q) ligand are sensitive to salt concentration, leading to reduced clearance levels of impurities at moderate salt concentrations (50–150 mM). In this report, membrane adsorbers incorporating four alternative salt tolerant anion exchange ligands were examined for impurity clearance: agmatine, tris‐2‐aminoethyl amine, polyhexamethylene biguanide (PHMB), and polyethyleneimine. Each of these ligands provided greater than 5 log reduction value (LRV) for viral clearance of phage ?X174 (pI ～ 6.7) at pH 7.5 and phage PR772 (pI ～ 4) at pH 4.2 in the presence of salt. Under these same conditions, the commercial Q membrane adsorber provided no clearance (zero LRV). Clearance of host‐cell protein at pH 7.5 was the most challenging test case; only PHMB maintained 1.5 LRV in 150 mM salt. The salt tolerance of PHMB was attributed to its large positive net charge through the presence of multiple biguanide groups that participated in electrostatic and hydrogen bonding interactions with the impurity molecules. On the basis of the results of this study, membrane adsorbers that incorporate salt tolerant anion exchange ligands provide a robust approach to impurity clearance during the purification of monoclonal antibodies. © 2009 American Institute of Chemical Engineers Biotechnol. Prog., 2009     

Adsorptive filtration: A case study for early impurity reduction in an Escherichia coli production process

Primary recovery of intracellular products from Escherichia coli requires cell disruption which leads to a massive release of process-related impurities burdening subsequent downstream process (DSP) unit operations. Especially, DNA and endotoxins challenge purification operations due to their size and concentrations. Consequently, an early reduction in impurities will not only simplify the production process but also increase robustness while alleviating the workload afterward. In the present work, we studied the proof of concept whether a nonwoven anion exchange filter material decreases soluble impurities immediately at the clarification step of E. coli DSP. In a first attempt, endotoxin burden was reduced by 4.6-fold and the DNA concentration by 3.6-fold compared to conventional depth filtration. A design of experiment for the adsorptive filtration approach was carried out to analyze the influence of different critical process parameters (CPPs) on impurity reduction. We showed that depending on the CPPs chosen, a DNA lowering of more than 3 log values, an endotoxin decrease of approximately 7 logs, and a minor HCP clearance of at least 0.3 logs could be achieved. Thus, we further revealed a chromatography column protecting effect when using adsorptive filtration beforehand.     

Clearance of solvents and small molecule impurities in antibody drug conjugates via ultrafiltration and diafiltration operation

Ultrafiltration and diafiltration (UF/DF) processes by tangential flow filtration (TFF) are frequently used for removal of solvents and small molecule impurities and for buffer exchange for biopharmaceutical products. Antibody-drug conjugates (ADCs) as an important class of biological therapeutics, carry unique solvents and small molecule impurities into the final UF/DF step as compared to standard antibody preparation. The production process of ADCs involves multiple chemical steps, for example, reduction and conjugation. The clearance of these solvents and small molecules by UF/DF, specifically the DF step, has been assessed and described herein. The rates of clearance for all the impurities in this study are close to the ideal clearance with no apparent interaction with either the protein or the TFF membrane and system. The effect of process variables during DF, such as pH, temperature, membrane loading, transmembrane pressure, and cross flow rate, has also been evaluated and found to have minimal impact on the clearance rate. These results demonstrate efficient clearance of solvents and small molecule impurities related to the ADC process by the DF process and provide a general data package to facilitate risk assessments based on the sieving factors and program specific needs.     

The Purity of Fluorescent Dyes: a Report Delivered to the Scientific Session of the Annual Meeting of the Biological Stain Commission

The Biological Stain Commission occasionally has been requested to certify fluorochromes as biological stains. Although formal certification is unlikely in the near future, the Commission is nevertheless concerned with the quality of these reagents. Commercial samples of fourteen fluorochromes were investigated for the presence of fluorescent organic impurities using reverse phase thin layer chromatography. Our findings suggest that some fluorochrome dyes are pure, but most are impure. Most fluorochromes vary in purity among vendors and among batches sold by single vendors. Impurities may be present at such high concentration that little of the presumed compound is present. Some impurities behave quite differently from the nominal dye. This may either create confusion or it might be useful. In the latter case, however, the impurity may occur only in a single batch. Impurities result from problems related to organic syntheses, separations, and economics. Solving those problems is often expensive, and what is expensive may not be performed. Fortunately, knowledge of synthetic chemistry often permits identification of fluorochromes likely to be impure. Moreover, predictions of likely staining effects of particular impurities can be made if appropriate structure-activity models are available. Possible actions by the Commission aimed at limiting the problems resulting from impurities of fluorescent dyes are noted.     

Influence of Peroxide Impurities in Povidone on the Stability of Selected β-Blockers with the Help of HPLC

A present study was conducted to investigate compatibility of β-blocker drugs( like atenolol, labetalol hydrochloride, bisoprolol fumarate, metoprolol succinate, carvedilol and propranolol hydrochloride) with the pharmaceutical excipient povidone. To check the influence of peroxide impurity present in povidone on the stability of β-blockers, a binary mixture technique has been adopted. The binary mixtures (1:1) of β-blockers with povidone excipient were stored for the duration of 6 months at accelerated conditions (40°C and 75% RH) and analyzed with the technique of high-performance liquid chromatography (HPLC). On analysis, HPLC results shows that, the percentage of total impurity for atenolol—2.15%, bisoprolol fumarate—3.55%, carvedilol—2.19%, and labetalol hydrochloride—1.89%, with respect to povidone. To verify the interaction of H₂O₂ present in povidone as an impurity, oxidative degradation of selected active pharmaceutical ingredients were performed and degradation profile were compared with that of degradation impurities generated in drug-excipient mixture at accelerated conditions. The relative retention time (RRT) of impurities generated in accelerated stability study samples resembles the RRT of degradation products generated by oxidative degradation of pure drugs. Thus, it confirms that degradation of β-blockers with povidone was mediated by organic peroxides present as an impurity in povidone.